Order Article Reprints

Cristóbal I, Torrejón B, Rubio J, Santos A, Pedregal M, Caramés C, Zazo S, Luque M, Sanz-Alvarez M, Madoz-Gúrpide J, et al. Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. Journal of Clinical Medicine. 2019; 8(3):346. https://doi.org/10.3390/jcm8030346

Cristóbal, Ion, Blanca Torrejón, Jaime Rubio, Andrea Santos, Manuel Pedregal, Cristina Caramés, Sandra Zazo, Melani Luque, Marta Sanz-Alvarez, Juan Madoz-Gúrpide, and et al. 2019. "Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer" Journal of Clinical Medicine 8, no. 3: 346. https://doi.org/10.3390/jcm8030346

Cristóbal, I., Torrejón, B., Rubio, J., Santos, A., Pedregal, M., Caramés, C., Zazo, S., Luque, M., Sanz-Alvarez, M., Madoz-Gúrpide, J., Rojo, F., & García-Foncillas, J. (2019). Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer. Journal of Clinical Medicine, 8(3), 346. https://doi.org/10.3390/jcm8030346